https://www.selleckchem.com/pr....oducts/Gefitinib.htm
64; 95% CI 2.10-3.31; P less then 0.001). The DDLT rate per 100 person-months was 11.86 for HCC patients vs 3.38 for non-HCC patients. The median time on the waiting list was 5.6 months for patients with HCC and 25 months for patients without HCC. CONCLUSION Our results demonstrated that, in our center, patients on the waiting list with HCC have a clear advantage over candidates listed with a calculated MELD score.BACKGROUND Intragastric balloon (IG use is indicated for patients whose BMI precludes the option of bariatric surgery or